KPCG_MOUSE - dbPTM
KPCG_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KPCG_MOUSE
UniProt AC P63318
Protein Name Protein kinase C gamma type
Gene Name Prkcg
Organism Mus musculus (Mouse).
Sequence Length 697
Subcellular Localization Cytoplasm . Cytoplasm, perinuclear region. Cell membrane
Peripheral membrane protein. Cell junction, synapse, synaptosome . Cell projection, dendrite . Translocates to synaptic membranes on stimulation.
Protein Description Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays diverse roles in neuronal cells and eye tissues, such as regulation of the neuronal receptors GRIA4/GLUR4 and GRIN1/NMDAR1, modulation of receptors and neuronal functions related to sensitivity to opiates, pain and alcohol, mediation of synaptic function and cell survival after ischemia, and inhibition of gap junction activity after oxidative stress. Binds and phosphorylates GRIA4/GLUR4 glutamate receptor and regulates its function by increasing plasma membrane-associated GRIA4 expression. In primary cerebellar neurons treated with the agonist 3,5-dihyidroxyphenylglycine, functions downstream of the metabotropic glutamate receptor GRM5/MGLUR5 and phosphorylates GRIN1/NMDAR1 receptor which plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. May be involved in the regulation of hippocampal long-term potentiation (LTP), but may be not necessary for the process of synaptic plasticity. May be involved in desensitization of mu-type opioid receptor-mediated G-protein activation in the spinal cord, and may be critical for the development and/or maintenance of morphine-induced reinforcing effects in the limbic forebrain. May modulate the functionality of mu-type-opioid receptors by participating in a signaling pathway which leads to the phosphorylation and degradation of opioid receptors. May also contribute to chronic morphine-induced changes in nociceptive processing. Plays a role in neuropathic pain mechanisms and contributes to the maintenance of the allodynia pain produced by peripheral inflammation. Plays an important role in initial sensitivity and tolerance to ethanol, by mediating the behavioral effects of ethanol as well as the effects of this drug on the GABA(A) receptors. During and after cerebral ischemia modulate neurotransmission and cell survival in synaptic membranes, and is involved in insulin-induced inhibition of necrosis, an important mechanism for minimizing ischemic injury. Required for the elimination of multiple climbing fibers during innervation of Purkinje cells in developing cerebellum. Is activated in lens epithelial cells upon hydrogen peroxide treatment, and phosphorylates connexin-43 (GJA1/CX43), resulting in disassembly of GJA1 gap junction plaques and inhibition of gap junction activity which could provide a protective effect against oxidative stress. Phosphorylates p53/TP53 and promotes p53/TP53-dependent apoptosis in response to DNA damage. Involved in the phase resetting of the cerebral cortex circadian clock during temporally restricted feeding. Stabilizes the core clock component ARNTL/BMAL1 by interfering with its ubiquitination, thus suppressing its degradation, resulting in phase resetting of the cerebral cortex clock. [PubMed: 23185022]
Protein Sequence MAGLGPGGGDSEGGPRPLFCRKGALRQKVVHEVKSHKFTARFFKQPTFCSHCTDFIWGIGKQGLQCQVCSFVVHRRCHEFVTFECPGAGKGPQTDDPRNKHKFRLHSYSSPTFCDHCGSLLYGLVHQGMKCSCCEMNVHRRCVRSVPSLCGVDHTERRGRLQLEIRAPTSDEIHITVGEARNLIPMDPNGLSDPYVKLKLIPDPRNLTKQKTKTVKATLNPVWNETFVFNLKPGDVERRLSVEVWDWDRTSRNDFMGAMSFGVSELLKAPVDGWYKLLNQEEGEYYNVPVADADNCSLLQKFEACNYPLELYERVRMGPSSSPIPSPSPSPTDSKRCFFGASPGRLHISDFSFLMVLGKGSFGKVMLAERRGSDELYAIKILKKDVIVQDDDVDCTLVEKRVLALGGRGPGGRPHFLTQLHSTFQTPDRLYFVMEYVTGGDLMYHIQQLGKFKEPHAAFYAAEIAIGLFFLHNQGIIYRDLKLDNVMLDAEGHIKITDFGMCKENVFPGSTTRTFCGTPDYIAPEIIAYQPYGKSVDWWSFGVLLYEMLAGQPPFDGEDEEELFQAIMEQTVTYPKSLSREAVAICKGFLTKHPGKRLGSGPDGEPTIRAHGFFRWIDWERLERLEIAPPFRPRPCGRSGENFDKFFTRAAPALTPPDRLVLASIDQADFQGFTYVNPDFVHPDARSPTSPVPVPVM
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationLGPGGGDSEGGPRPL
CCCCCCCCCCCCCCC
41.2218056256
47PhosphorylationARFFKQPTFCSHCTD
HHHHCCCCCHHHHHH
34.48-
70PhosphorylationGLQCQVCSFVVHRRC
CCCCCEEEEEEECCC
23.4025521595
132PhosphorylationVHQGMKCSCCEMNVH
HHCCCCCCCHHCHHH
19.1129899451
148PhosphorylationRCVRSVPSLCGVDHT
HHHHHCHHHCCCCCC
33.8518056256
169PhosphorylationQLEIRAPTSDEIHIT
EEEEECCCCCEEEEE
48.0719060867
170PhosphorylationLEIRAPTSDEIHITV
EEEECCCCCEEEEEE
31.9922817900
176PhosphorylationTSDEIHITVGEARNL
CCCEEEEEEECHHCC
14.32-
195PhosphorylationPNGLSDPYVKLKLIP
CCCCCCCCEEEEECC
18.4020415495
197UbiquitinationGLSDPYVKLKLIPDP
CCCCCCEEEEECCCC
33.7822790023
199UbiquitinationSDPYVKLKLIPDPRN
CCCCEEEEECCCCCC
38.3622790023
250PhosphorylationEVWDWDRTSRNDFMG
EEECCCCCCCCCHHH
29.57-
296S-nitrosylationPVADADNCSLLQKFE
CCCCCCCCCHHHHHH
2.8922178444
296S-nitrosocysteinePVADADNCSLLQKFE
CCCCCCCCCHHHHHH
2.89-
297PhosphorylationVADADNCSLLQKFEA
CCCCCCCCHHHHHHH
38.0725521595
305S-nitrosylationLLQKFEACNYPLELY
HHHHHHHCCCCHHHH
3.8424895380
312PhosphorylationCNYPLELYERVRMGP
CCCCHHHHHHHHCCC
7.7218034455
320PhosphorylationERVRMGPSSSPIPSP
HHHHCCCCCCCCCCC
37.4124925903
321PhosphorylationRVRMGPSSSPIPSPS
HHHCCCCCCCCCCCC
43.1824925903
322PhosphorylationVRMGPSSSPIPSPSP
HHCCCCCCCCCCCCC
31.0525521595
326PhosphorylationPSSSPIPSPSPSPTD
CCCCCCCCCCCCCCC
38.4425521595
328PhosphorylationSSPIPSPSPSPTDSK
CCCCCCCCCCCCCCC
42.2025521595
330PhosphorylationPIPSPSPSPTDSKRC
CCCCCCCCCCCCCCC
44.7825521595
332PhosphorylationPSPSPSPTDSKRCFF
CCCCCCCCCCCCCCC
58.1925521595
334PhosphorylationPSPSPTDSKRCFFGA
CCCCCCCCCCCCCCC
25.2022324799
335UbiquitinationSPSPTDSKRCFFGAS
CCCCCCCCCCCCCCC
56.8722790023
342PhosphorylationKRCFFGASPGRLHIS
CCCCCCCCCCCEEEC
28.4122817900
364UbiquitinationLGKGSFGKVMLAERR
ECCCCHHHHEEEECC
23.5922790023
373PhosphorylationMLAERRGSDELYAIK
EEEECCCCCCEEEEE
26.5422817900
380AcetylationSDELYAIKILKKDVI
CCCEEEEEEECCCEE
33.5419860959
479MethylationHNQGIIYRDLKLDNV
CCCCEEECCCCCCCE
32.1730988853
503UbiquitinationITDFGMCKENVFPGS
ECCCCCCCCCCCCCC
43.3522790023
510PhosphorylationKENVFPGSTTRTFCG
CCCCCCCCCCEEECC
27.1829899451
511PhosphorylationENVFPGSTTRTFCGT
CCCCCCCCCEEECCC
26.6424925903
512PhosphorylationNVFPGSTTRTFCGTP
CCCCCCCCEEECCCC
29.4324925903
514PhosphorylationFPGSTTRTFCGTPDY
CCCCCCEEECCCCCC
22.6125521595
518PhosphorylationTTRTFCGTPDYIAPE
CCEEECCCCCCCCCH
17.7325521595
521PhosphorylationTFCGTPDYIAPEIIA
EECCCCCCCCCHHHE
10.5325619855
529PhosphorylationIAPEIIAYQPYGKSV
CCCHHHEECCCCCCC
10.3025619855
532PhosphorylationEIIAYQPYGKSVDWW
HHHEECCCCCCCCHH
22.9724925903
587UbiquitinationREAVAICKGFLTKHP
HHHHHHHHHHHHCCC
46.7322790023
592UbiquitinationICKGFLTKHPGKRLG
HHHHHHHCCCCCCCC
50.3722790023
639PhosphorylationRPRPCGRSGENFDKF
CCCCCCCCCCCHHHH
35.4225521595
645UbiquitinationRSGENFDKFFTRAAP
CCCCCHHHHHHHCCC
37.9422790023
648PhosphorylationENFDKFFTRAAPALT
CCHHHHHHHCCCCCC
23.64-
655PhosphorylationTRAAPALTPPDRLVL
HHCCCCCCCCCCEEE
34.5825521595
664PhosphorylationPDRLVLASIDQADFQ
CCCEEEEECCHHHCC
23.6529899451
674PhosphorylationQADFQGFTYVNPDFV
HHHCCCCEEECCCCC
33.1317904530
675PhosphorylationADFQGFTYVNPDFVH
HHCCCCEEECCCCCC
8.9320415495
687PhosphorylationFVHPDARSPTSPVPV
CCCCCCCCCCCCCCC
33.9625521595
689PhosphorylationHPDARSPTSPVPVPV
CCCCCCCCCCCCCCC
47.0825521595
690PhosphorylationPDARSPTSPVPVPVM
CCCCCCCCCCCCCCC
27.5525521595

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
514TPhosphorylationKinasePKCDP28867
PSP
514TPhosphorylationKinasePDPK1Q9Z2A0
Uniprot
655TPhosphorylationKinasePRKCGP63318
GPS
674TPhosphorylationKinasePRKCGP63318
GPS
675YPhosphorylationKinaseSYKP48025
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
674TPhosphorylation

17904530

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KPCG_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Oops, there are no PPI records of KPCG_MOUSE !!

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KPCG_MOUSE

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations.";
Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.;
Mol. Cell. Proteomics 6:283-293(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-322; SER-330; THR-514;THR-518; THR-655 AND SER-687, SUBCELLULAR LOCATION, TISSUESPECIFICITY, AND MASS SPECTROMETRY.
"Abnormal features in mutant cerebellar Purkinje cells lackingjunctophilins.";
Ikeda A., Miyazaki T., Kakizawa S., Okuno Y., Tsuchiya S., Myomoto A.,Saito S.Y., Yamamoto T., Yamazaki T., Iino M., Tsujimoto G.,Watanabe M., Takeshima H.;
Biochem. Biophys. Res. Commun. 363:835-839(2007).
Cited for: PHOSPHORYLATION AT THR-514; THR-655 AND THR-674, SUBCELLULAR LOCATION,FUNCTION, AND TISSUE SPECIFICITY.
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain.";
Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.;
J. Proteome Res. 7:311-318(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195 AND TYR-312, ANDMASS SPECTROMETRY.

TOP